🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌶️🌡️Summary of my uropathology for urologists and oncologists series! 👉check it out! and retweet if you like! UroToday.com OncoAlert European Association of Urology (EAU) EAU Young Academics EAU Young Academics Urologist. Uro-Tech group EAU Patient Information Niklas Klümper onkowissen x.com/Markuseckstein…

Am 15. Mai 2025 würde Else Kröner 100 Jahre alt werden. Aus diesem Grund schauen wir in den nächsten Wochen auf ihr Leben und Wirken zurück. Dabei würdigen wir ihre wirtschaftlichen Leistungen als Unternehmerin sowie ihr soziales Engagement als Stifterin. sohub.io/qh8f

Else Kröner Fresenius Prize for Medical Research 2025: Anastasia Khvorova, professor of RNA therapeutics UMass Chan Medical School, is being honored with 2.5 million € for her pioneering work in the field of RNA-based therapies. Here is a preview of the award film. #EKFprize25 #RNA #Huntington

Die EKFS ehrte heute im Rahmen des zweiten Alumni-Tags in Frankfurt am Main fünf herausragende Wissenschaftlerinnen und Wissenschaftler mit dem Publikationspreis 2025. Herzlichen Glückwunsch an Ricardo Grieshaber-Bouyer, Susanne Meinert, Jan-Michel Heger, Felicitas E. Hengel, Marcel S. Woo

Dr. Donald Gleason is unequivocally the most pivotal figure in the history of urologic surgical pathology and the International Society of Urological Pathology (ISUP). Despite subsequent revisions, the original Gleason grading system, established in 1966, has withstood the test

Our research team is expanding!!!.. we are excited to welcome Gabriela M. Díaz, MD and Can Aydogdu Universität München as our new Urologic Oncology Research Assistants. Welcome Cleveland Clinic Urology .. what an incredible year ahead with these two superstars💫💫 Chris Weight

Honored to host our Clinical Advisors Niklas Klümper and Markus Eckstein and our collaborator Johannes Brägelmann at our UK office this week. As part of their visit, our team was treated to a deep-dive seminar on NECTIN4 gene amplification. #PrecisionOncology at its finest!

Recombinant BCG phase I/II trial addresses #BladderCancer treatment shortage - Joshua Meeks Northwestern Feinberg School of Medicine sits down with Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center to discuss the potential of recombinant BCG in a phase I/II trial. Watch to learn more about this innovative approach >

What a fantastic and intense meeting with Bicycle Therapeutics in Cambridge !exciting journey to travel on the nectin4 amplification road! Niklas Klümper #precision oncology

Great overview by Raffaele Colombo ! ADCs and small peptides are so exciting - they are and will be the key for future precision oncology UroToday.com OncoAlert Niklas Klümper

Ever wondered how to cost effectively implement molecular subtyping of muscle invasive #bladder #cancer ? We just published a publicly available pipeline relying on NextFlow and Quantseq to assign molecular consensus subtype in large scale! Costs per sample <200 💵!!!!! ➡️ ready

4.#CLONEVO: Preoperative abemaciclib for cisplatin-ineligible muscle-invasive bladder cancer (MIBC) with molecular response assessment. Abema resulted in pathologic complete response in 18.8% (3/16) and downstaging in 31.3% (5/16).

🚨 New preprint drop! MOSAIC builds a pan-cancer spatial + single-cell multi-omics atlas of thousands of tumors, exposing the fine-grained mosaic of intra-tumoral heterogeneity and immune niches. A game-changer for #PrecisionOncology and data-hungry AI models. More to come (much

These are huge results!! Curious to see full data !!

18.8% is in the range of complete resection rates for TURB only. That speaks for no meaningful responses at all.

ASCO25 Zelenectide vedotin (BT8009) + pembro: ORR 65% (25% CR) in 1L cis-ineligible la/mUC (incl. PS 2). 👉#bicycle toxin conjugate (small peptide) targeting Nectin-4, with renal clearance (vs hepatic for EV). 👆Encouraging tolerability Matt Galsky Ignacio Duran Andrea Necchi

🎥 Looking back on a special evening at the Städel Museum in Frankfurt on 15 May when EKFS awarded the Else Kröner Fresenius Prize for Medical Research to Prof. Anastasia Khvorova and celebrated Else Kröner’s 100th birthday together with the company Fresenius. 🏆 🎉 UMass Chan Medical School

Amazing overview of the emerging field of BCG-unresponsive NMIBC by Joshua Meeks at Uromigos Drug development in BCG-unresponsive NMIBC is gaining a lot of traction - i agree that we now need randomized trials. In addition, we should not overlook intravesical